Elisabeth Oelmann
Chief Tech/Sci/R&D Officer chez NUCANA PLC
Postes actifs de Elisabeth Oelmann
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NUCANA PLC | Chief Tech/Sci/R&D Officer | 01/09/2020 | - |
Historique de carrière de Elisabeth Oelmann
Anciens postes connus de Elisabeth Oelmann
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
PRA International LLC
 PRA International LLC Pharmaceuticals: OtherHealth Technology Part of ICON plc, PRA International LLC is a clinical research organization. The private company is based in Raleigh, NC. | Corporate Officer/Principal | - | - |
| Freie Universität Berlin | Corporate Officer/Principal | - | - |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Chief Tech/Sci/R&D Officer | - | - |
Formation de Elisabeth Oelmann
| University of Münster | Doctorate Degree |
Statistiques
Internationale
| Allemagne | 3 |
| Royaume-Uni | 3 |
| Etats-Unis | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NUCANA PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
PRA International LLC
PRA International LLC Pharmaceuticals: OtherHealth Technology Part of ICON plc, PRA International LLC is a clinical research organization. The private company is based in Raleigh, NC. | Health Technology |
- Bourse
- Insiders
- Elisabeth Oelmann
- Expérience
